Journal
JOURNAL OF CONTROLLED RELEASE
Volume 244, Issue -, Pages 83-97Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2016.11.014
Keywords
Site-specific nuclease; Therapeutic gene editing; Non-viral delivery; Viral vectors
Funding
- Natural Science Foundation of China [31600686]
- ShanghaiTech University
Ask authors/readers for more resources
The advent of site-specific nucleases, particularly CRISPR/Cas9, provides researchers with the unprecedented ability to manipulate genomic sequences. These nucleases are used to create model cell lines, engineer metabolic pathways, produce transgenic animals and plants, perform genome-wide functional screen and, most importantly, treat human diseases that are difficult to tackle by traditional medications. Considerable efforts have been devoted to improving the efficiency and specificity of nucleases for clinical applications. However, safe and efficient delivery methods remain the major obstacle for therapeutic gene editing. In this review, we summarize the recent progress on nuclease delivery methods, highlight their impact on the outcomes of gene editing and discuss the potential of different delivery approaches for therapeutic gene editing. (C) 2016 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available